21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
20.14.Z - Manufacture of other organic basic chemicals
20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
73.20.Z - Market research and public opinion polling
77.39.Z - Rental and leasing of other machinery, equipment, and tangible assets, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 18 | 19,1 | 16 | -16,4 |
EBITDA | 26,3 | 26,7 | 23,6 | -11,5 |
Short time liabilities | 37,9 | 50,6 | 44,7 | -11,5 |
Equity capital | 29 | 37,7 | 45,4 | 20,7 |
Operating profit (EBIT) | 23,2 | 23 | 19,9 | -13,5 |
Assets | 117,1 | 133,6 | 140,7 | 5,3 |
Net profit (loss) | 13,1 | 15,4 | 13,8 | -10,4 |
Cash | 2,5 | 1,3 | 0,6 | -53,7 |
Net income from sale | 131,8 | 161,9 | 173,8 | 7,4 |
Liabilities and provisions for liabilities | 88,1 | 96 | 95,2 | -0,8 |
Working assets | 45,8 | 60,5 | 52,4 | -13,3 |
Depreciation | 3,1 | 3,7 | 3,7 | 0,5 |
% | % | % | p.p. | |
Profitability of capital | 45,1 | 40,9 | 30,4 | -10,5 |
Equity capital to total assets | 24,8 | 28,2 | 32,3 | 4,1 |
Gross profit margin | 13,6 | 11,8 | 9,2 | -2,6 |
EBITDA Margin | 19,9 | 16,5 | 13,6 | -2,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 105 | 114 | 94 | -20 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane